Cargando…

Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways

Chemotherapy-induced peripheral neuropathy (CIPN) is a serious dose-limiting toxicity of many anti-neoplastic agents, especially paclitaxel, and oxaliplatin. Up to 62% of patients receiving paclitaxel regimens turn out to develop CIPN. Unfortunately, there are so few agents proved effective for prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fei-ze, Xu, Wen-juan, Deng, Bo, Liu, Si-da, Deng, Chao, Wu, Meng-yu, Gao, Yu, Jia, Li-qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127630/
https://www.ncbi.nlm.nih.gov/pubmed/30233366
http://dx.doi.org/10.3389/fphar.2018.00956
_version_ 1783353514571857920
author Wu, Fei-ze
Xu, Wen-juan
Deng, Bo
Liu, Si-da
Deng, Chao
Wu, Meng-yu
Gao, Yu
Jia, Li-qun
author_facet Wu, Fei-ze
Xu, Wen-juan
Deng, Bo
Liu, Si-da
Deng, Chao
Wu, Meng-yu
Gao, Yu
Jia, Li-qun
author_sort Wu, Fei-ze
collection PubMed
description Chemotherapy-induced peripheral neuropathy (CIPN) is a serious dose-limiting toxicity of many anti-neoplastic agents, especially paclitaxel, and oxaliplatin. Up to 62% of patients receiving paclitaxel regimens turn out to develop CIPN. Unfortunately, there are so few agents proved effective for prevention or management of CIPN. The reason for the current situation is that the mechanisms of CIPN are still not explicit. Traditional Chinese Medicine (TCM) has unique advantages for dealing with complex diseases. Wen-Luo-Tong (WLT) is a TCM ointment for topical application. It has been applied for prevention and management of CIPN clinically for more than 10 years. Previous animal experiments and clinical studies had manifested the availability of WLT. However, due to the unclear mechanisms of WLT, further transformation has been restricted. To investigate the therapeutic mechanisms of WLT, a metabolomic method on the basis of UPLC- MS was developed in this study. Multivariate analysis techniques, such as principal component analysis (PCA) and partial least squares discriminate analysis (PLS-DA), were applied to observe the disturbance in the metabolic state of the paclitaxel-induced peripheral neuropathy (PIPN) rat model, as well as the recovering tendency of WLT treatment. A total of 19 significant variations associated with PIPN were identified as biomarkers. Results of pathway analysis indicated that the metabolic disturbance of pathways of linoleic acid (LA) metabolism and glycerophospholipid metabolism. WLT attenuated mechanical allodynia and rebalanced the metabolic disturbances of PIPN by primarily regulating LA and glycerophospholipid metabolism pathway. Further molecular docking analysis showed some ingredients of WLT, such as hydroxysafflor yellow A (HSYA), icariin, epimedin B and 4-dihydroxybenzoic acid (DHBA), had high affinity to plenty of proteins within these two pathways.
format Online
Article
Text
id pubmed-6127630
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61276302018-09-19 Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways Wu, Fei-ze Xu, Wen-juan Deng, Bo Liu, Si-da Deng, Chao Wu, Meng-yu Gao, Yu Jia, Li-qun Front Pharmacol Pharmacology Chemotherapy-induced peripheral neuropathy (CIPN) is a serious dose-limiting toxicity of many anti-neoplastic agents, especially paclitaxel, and oxaliplatin. Up to 62% of patients receiving paclitaxel regimens turn out to develop CIPN. Unfortunately, there are so few agents proved effective for prevention or management of CIPN. The reason for the current situation is that the mechanisms of CIPN are still not explicit. Traditional Chinese Medicine (TCM) has unique advantages for dealing with complex diseases. Wen-Luo-Tong (WLT) is a TCM ointment for topical application. It has been applied for prevention and management of CIPN clinically for more than 10 years. Previous animal experiments and clinical studies had manifested the availability of WLT. However, due to the unclear mechanisms of WLT, further transformation has been restricted. To investigate the therapeutic mechanisms of WLT, a metabolomic method on the basis of UPLC- MS was developed in this study. Multivariate analysis techniques, such as principal component analysis (PCA) and partial least squares discriminate analysis (PLS-DA), were applied to observe the disturbance in the metabolic state of the paclitaxel-induced peripheral neuropathy (PIPN) rat model, as well as the recovering tendency of WLT treatment. A total of 19 significant variations associated with PIPN were identified as biomarkers. Results of pathway analysis indicated that the metabolic disturbance of pathways of linoleic acid (LA) metabolism and glycerophospholipid metabolism. WLT attenuated mechanical allodynia and rebalanced the metabolic disturbances of PIPN by primarily regulating LA and glycerophospholipid metabolism pathway. Further molecular docking analysis showed some ingredients of WLT, such as hydroxysafflor yellow A (HSYA), icariin, epimedin B and 4-dihydroxybenzoic acid (DHBA), had high affinity to plenty of proteins within these two pathways. Frontiers Media S.A. 2018-08-28 /pmc/articles/PMC6127630/ /pubmed/30233366 http://dx.doi.org/10.3389/fphar.2018.00956 Text en Copyright © 2018 Wu, Xu, Deng, Liu, Deng, Wu, Gao and Jia. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wu, Fei-ze
Xu, Wen-juan
Deng, Bo
Liu, Si-da
Deng, Chao
Wu, Meng-yu
Gao, Yu
Jia, Li-qun
Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways
title Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways
title_full Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways
title_fullStr Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways
title_full_unstemmed Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways
title_short Wen-Luo-Tong Decoction Attenuates Paclitaxel-Induced Peripheral Neuropathy by Regulating Linoleic Acid and Glycerophospholipid Metabolism Pathways
title_sort wen-luo-tong decoction attenuates paclitaxel-induced peripheral neuropathy by regulating linoleic acid and glycerophospholipid metabolism pathways
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127630/
https://www.ncbi.nlm.nih.gov/pubmed/30233366
http://dx.doi.org/10.3389/fphar.2018.00956
work_keys_str_mv AT wufeize wenluotongdecoctionattenuatespaclitaxelinducedperipheralneuropathybyregulatinglinoleicacidandglycerophospholipidmetabolismpathways
AT xuwenjuan wenluotongdecoctionattenuatespaclitaxelinducedperipheralneuropathybyregulatinglinoleicacidandglycerophospholipidmetabolismpathways
AT dengbo wenluotongdecoctionattenuatespaclitaxelinducedperipheralneuropathybyregulatinglinoleicacidandglycerophospholipidmetabolismpathways
AT liusida wenluotongdecoctionattenuatespaclitaxelinducedperipheralneuropathybyregulatinglinoleicacidandglycerophospholipidmetabolismpathways
AT dengchao wenluotongdecoctionattenuatespaclitaxelinducedperipheralneuropathybyregulatinglinoleicacidandglycerophospholipidmetabolismpathways
AT wumengyu wenluotongdecoctionattenuatespaclitaxelinducedperipheralneuropathybyregulatinglinoleicacidandglycerophospholipidmetabolismpathways
AT gaoyu wenluotongdecoctionattenuatespaclitaxelinducedperipheralneuropathybyregulatinglinoleicacidandglycerophospholipidmetabolismpathways
AT jialiqun wenluotongdecoctionattenuatespaclitaxelinducedperipheralneuropathybyregulatinglinoleicacidandglycerophospholipidmetabolismpathways